These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
569 related articles for article (PubMed ID: 33756128)
1. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer. Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128 [TBL] [Abstract][Full Text] [Related]
2. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer. Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868 [TBL] [Abstract][Full Text] [Related]
3. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p. Zang H; Li Y; Zhang X; Huang G Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer. Yu SJ; Yang L; Hong Q; Kuang XY; Di GH; Shao ZM BMC Cancer; 2018 Jan; 18(1):74. PubMed ID: 29329575 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p. Ren XY; Han YD; Lin Q Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4822-4835. PubMed ID: 32432745 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells. Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA TPT1-AS1 sensitizes breast cancer cell to paclitaxel and inhibits cell proliferation by miR-3156-5p/caspase 2 axis. Huang Y; Zheng Y; Shao X; Shi L; Li G; Huang P Hum Cell; 2021 Jul; 34(4):1244-1254. PubMed ID: 33999360 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation. Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529 [TBL] [Abstract][Full Text] [Related]
9. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation. Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058 [TBL] [Abstract][Full Text] [Related]
10. miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming. Nguyen PNN; Choo KB; Huang CJ; Sugii S; Cheong SK; Kamarul T Stem Cell Res Ther; 2017 Sep; 8(1):214. PubMed ID: 28962647 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells. Shi Y; Gong W; Lu L; Wang Y; Ren J Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305 [TBL] [Abstract][Full Text] [Related]
12. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4. Tao L; Wu YQ; Zhang SP Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-15a-5p down-regulation inhibits cervical cancer by targeting TP53INP1 in vitro. Zhao XQ; Tang H; Yang J; Gu XY; Wang SM; Ding Y Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8219-8229. PubMed ID: 31646552 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19. Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515 [TBL] [Abstract][Full Text] [Related]
15. 17β-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. Zhang C; Zhao J; Deng H Mol Cell Biochem; 2013 Jul; 379(1-2):201-11. PubMed ID: 23568502 [TBL] [Abstract][Full Text] [Related]
16. miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression. Chatterjee A; Chattopadhyay D; Chakrabarti G PLoS One; 2014; 9(4):e95716. PubMed ID: 24755562 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis. Li G; Yan X J Orthop Surg Res; 2023 Nov; 18(1):890. PubMed ID: 37993867 [TBL] [Abstract][Full Text] [Related]
18. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer. Tao WY; Liang XS; Liu Y; Wang CY; Pang D Int J Biol Sci; 2015; 11(1):48-58. PubMed ID: 25552929 [TBL] [Abstract][Full Text] [Related]
19. STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells. Liao XH; Xiang Y; Yu CX; Li JP; Li H; Nie Q; Hu P; Zhou J; Zhang TC Oncotarget; 2017 Feb; 8(9):15763-15774. PubMed ID: 28178652 [TBL] [Abstract][Full Text] [Related]
20. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. Wei Q; Li YX; Liu M; Li X; Tang H IUBMB Life; 2012 Aug; 64(8):697-704. PubMed ID: 22730212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]